Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

241
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
241
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

126
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
126
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

268
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
268
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

91
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
91
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

198
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
198
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

123
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
123

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Characterization of innate immune cells with regulatory functions in subjects with a remote history of Kawasaki disease who lack natural regulatory T cell specificities.

Immunology letters·2026
Same author

Acute Intensification May Reduce Persistent Coronary Artery Damage from Kawasaki Disease in Infants Younger Than 6 Months.

The Journal of pediatrics·2026
Same author

Infections of Selected Nonvalvular Cardiovascular Devices: A Science Advisory From the American Heart Association.

Journal of the American Heart Association·2026
Same author

Correction to: 2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same author

Catheter Ablation for Supraventricular Tachyarrhythmias in Adults With Total Cavopulmonary Connection Fontan Palliation.

JACC. Clinical electrophysiology·2026
Same author

Minimal correlation but complementary diagnostic utility for plasma cell-free RNA and proteins.

Communications medicine·2026

相关实验视频

Updated: Dec 1, 2025

Measuring Cardiac Autonomic Nervous System ANS Activity in Children
09:45

Measuring Cardiac Autonomic Nervous System ANS Activity in Children

Published on: April 29, 2013

21.3K

对儿童多系统炎症综合征的心脏参与的审查

Tarek Alsaied1, Adriana H Tremoulet2, Jane C Burns2

  • 1The Heart Institute, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, OH(T.A., S.M.L.).

Circulation
|November 9, 2020
PubMed
概括
此摘要是机器生成的。

儿童多系统炎症综合征 (MIS-C) 是COVID-19感染后的一种罕见但严重的疾病. 它引起严重的炎症, 特别影响心脏, 需要立即的医疗照顾.

关键词:
美国皮肤粘膜淋巴结综合征儿童多系统炎症疾病,与COVID-19相关一个冲击

更多相关视频

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy
06:38

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy

Published on: September 26, 2025

804

相关实验视频

Last Updated: Dec 1, 2025

Measuring Cardiac Autonomic Nervous System ANS Activity in Children
09:45

Measuring Cardiac Autonomic Nervous System ANS Activity in Children

Published on: April 29, 2013

21.3K
Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy
06:38

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy

Published on: September 26, 2025

804

科学领域:

  • 儿童传染病
  • 儿童心脏病学
  • 免疫学

背景情况:

  • 由SARS-CoV-2引起的COVID-19可能会导致儿童患有称为MIS-C的严重炎症.
  • MIS-C与毒性休克综合征和川崎病有相同的特征,报告的病例超过600例.
  • 这种综合症对美国的黑人和西班牙裔儿童的影响不成比例.

研究的目的:

  • 审查已公布的MIS-C数据,特别关注心脏并发症.
  • 为MIS-C儿童进行心脏评估和随访提供临床指导.

主要方法:

  • 关于MIS-C的已发表数据的文献审查.
  • 对临床表现的分析,重点是心血管表现.
  • 目前治疗策略和结果的总结.

主要成果:

  • 通常在SARS-CoV-2感染后几周出现MIS-C,通常伴有发烧和胃肠道症状.
  • 常见的心脏问题包括心室功能障碍,冠状动脉扩张/动脉瘤和心律失常.
  • 严重的病例可能导致冲击,需要密集的支持,包括机械通风和ECMO.

结论:

  • 儿童的MIS-C是COVID-19后的一种严重并发症,其特征是系统性炎症和频繁的心脏干扰.
  • 免疫调节治疗是标准的,大多数儿童都能康复,但长期后果尚不清楚.
  • 密切的心脏监测和随访对于管理MIS-C患者至关重要.